Skip to main content
. 2022 Feb 3;71(3):281–287. doi: 10.1538/expanim.21-0186

Fig. 3.

Fig. 3.

Kaplan–Meier survival curves. SHAM, no shock; HS, hemorrhagic shock; HS+DEX, hemorrhagic shock with dexmedetomidine; HS+DEX/MLA, hemorrhagic shock with dexmedetomidine and methyllycaconitine citrate; HS+MLA, hemorrhagic shock with methyllycaconitine citrate.